Cargando…
Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
Autores principales: | Kearns, Donovan G., Chat, Vipawee S., Uppal, Shelley, Wu, Jashin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526625/ https://www.ncbi.nlm.nih.gov/pubmed/33010318 http://dx.doi.org/10.1016/j.jaad.2020.09.069 |
Ejemplares similares
-
Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020) -
Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020) -
Applying to dermatology residency during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020) -
Response to: “Applying to dermatology residency during the COVID-19 pandemic”
por: Alia, Erisa, et al.
Publicado: (2021) -
Letter to the Editor regarding “Monkeypox emerges on a global scale: A historical review and dermatological primer”
por: Wang, Yaojun, et al.
Publicado: (2023)